Ditchcarbon
  • Contact
  1. Organizations
  2. Aspen Pharmacare
Public Profile
Pharmaceutical Preparation Manufacturing
ZA
updated a month ago

Aspen Pharmacare

Company website

Aspen Pharmacare, a leading global pharmaceutical company headquartered in South Africa (ZA), has established itself as a key player in the healthcare industry since its founding in 1850. With a strong presence in over 50 countries, Aspen operates primarily in the areas of generic and branded pharmaceuticals, as well as consumer healthcare products. The company is renowned for its diverse portfolio, which includes anaesthetics, thrombosis, and oncology medications, setting it apart through a commitment to quality and innovation. Aspen's strategic acquisitions and partnerships have bolstered its market position, making it one of the largest pharmaceutical manufacturers in Africa. Notable achievements include its rapid expansion into international markets and a focus on sustainable healthcare solutions, reinforcing its reputation as a trusted provider in the global pharmaceutical landscape.

DitchCarbon Score

How does Aspen Pharmacare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

56

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Aspen Pharmacare's score of 56 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.

72%

Let us know if this data was useful to you

Aspen Pharmacare's reported carbon emissions

In 2024, Aspen Pharmacare reported total carbon emissions of approximately 98,550,000 kg CO2e, comprising 6,429,000 kg CO2e from Scope 1 and 92,121,000 kg CO2e from Scope 2 emissions. This data reflects their operations in South Africa (ZA) and globally, with a revenue of about USD 2.45 billion. Aspen has set ambitious climate commitments, aiming to reduce global carbon dioxide emissions by 45% by 2030 relative to 2010 levels, with a long-term goal of achieving net zero emissions around mid-century. These targets are based on the best available scientific knowledge and consider equity and sustainable development. The company has previously achieved significant reductions, including a 64% decrease in Scope 1 emissions from 18,896,000 kg CO2e to 6,774,000 kg CO2e between 2012 and 2013, and a 44% reduction in Scope 2 emissions from 158,035,000 kg CO2e to 88,008,000 kg CO2e in the same period. Aspen's climate strategy is aligned with industry standards and reflects a commitment to sustainability, as evidenced by their ongoing efforts to monitor and report emissions transparently.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201020112012201320142015201620172018201920202021202220232024
Scope 1
16,609,000
-
0,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
37,278,000
00,000,000
00,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
00,000,000
-
-
-
-
-
-
-
-
-
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Aspen Pharmacare's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Aspen Pharmacare is in ZA, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Aspen Pharmacare is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Mallinckrodt plc

IE
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Lannett Company, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Upjohn Inc.

US
•
Financial intermediation services, except insurance and pension funding services (65)
Updated about 1 month ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Teva Pharmaceuticals

IL
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251022.7
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy